Multiple Sclerosis Center, Swedish Neuroscience Institute

Seattle, Washington 98122

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
Relapsing Remitting Multiple Sclerosis Clinical Trial
Evaluating the Efficacy and Safety of Transitioning Patients From Natalizumab to Ocrelizumab
Status: Enrolling, Phase
Updated: 12/31/1969
Multiple Sclerosis Center, Swedish Neuroscience Institute
mi
from
Seattle, WA
Click here to add this to my saved trials